2008 Minority-Serving Institution Faculty Scholars in Cancer Research

	Joseph Agyin, Ph.D., UT Health Science Center, San Antonio, TX. Abstract # 3254. BU-32: A novel proteasome inhibitor for breast cancer
	Wellington Ayensu, M.D., Jackson State University, Jackson, MS. Abstract # 4264. Transforming growth factor-beta signaling components: Expression in normal and neoplastic tissues
	Hareesh Babu Nair Bhaskaran, Ph.D., UT Health Science Center, San Antonio, TX. Abstract # 1223. Therapeutic modulation of estrogen receptor in ovarian cancer cells by ER-β agonist nanoparticles
	Hassan Brim, Ph.D., Howard University, Washington, DC. Abstract # 2649. New methylation profile and high microsatellite instability in African-American colon cancer
	Bumpers, Harvey, M.D., Morehouse School of Medicine, Atlanta, GA. Abstract # 2385. Effects of a novel apoptotic peptide (nefm1) on human breast cancers
	Bandana Chatterjee, Ph.D., UT Health Science Center, San Antonio, TX.
	Ruben Gonzalez, Ph.D., Morehouse School of Medicine, Atlanta, GA. Abstract# 1078. Differential signaling mechanisms for leptin regulation of angiogenesis-related molecules in endometrial and breast cancer cells
	Barbara Graham, Ph.D., Jackson State University, Jackson, MS.
	Rebecca Hartley, Ph.D., University of New Mexico, Albuquerque, NM.
	Minnie Holmes-McNary, Ph.D., North Carolina A&T State University, Greensboro, NC.
	Tamaro Hudson, Ph.D., Howard University, Washington, DC.
	Ernest Izevbigie, Ph.D., Jackson State University, Jackson, MS. Abstract # 618. A potential novel botanical agent for cancer treatment
	Nameer Kirma, Ph.D., UT Health Science Center, San Antonio, TX. Abstract # 5202. Transforming growth factor beta induces the expression and promoter 1 activity of the oncogene c-fms in cervical and ovarian cancer cells and immortalized endometrial cells
	Bernard Kwabi-Addo, Ph.D., Howard University, Washington, DC.
	Rong Li, Ph.D., University of Texas, San Antonio, TX.
	Babatunde Oyajobi, M.D., UT Health Science Center, San Antonio, TX. Abstract # 3267. Bortezomib significantly delays development of paraplegia in the 5TGM1 murine model of myeloma bone disease
	Anita Patlolla, Ph.D., Jackson State University, Jackson, MS. Abstract # 5591. DNA damaging effect of malathion in the peripheral blood leukocytes of Sprague-Dawley rats
	Quincy Quick, Ph.D., Grambling State University, Grambling, LA. Abstract # 1415. Epothilone B induces glioblastoma cell death via survivin down regulation and tubulin redistribution
	Saleh Rahman, Ph.D., Florida A&M University, Tallahassee, FL. Abstract # 499. Disparities in breast cancer screening and stage at diagnosis among minority women: lessons from colorado mammography project
	Romonia Reams, Ph.D., Florida A&M University, Tallahassee, FL. Abstract # 4267. Gene expressing profile of prostate tumors in African American and white males: a pilot project study
	Kinfe Redda, Ph.D., Florida A&M University, Tallahassee, FL.
	Yoedono Sovyahandi, Ph.D., Oakwood College, Huntsville, AL.
	Marta Torroella-Kouri, Ph.D., University of Miami Miller School of Medicine, Miami, FL. Abstract # 250. Differential expression of STAT1 and STAT3 in peritoneal and tumor-associated macrophages from mice bearing advanced tumors contribute to their diverse immunosuppressive properties
	Shanita Williams-Brown, Ph.D., Morehouse School of Medicine, Atlanta, GA.
	Beatriz Zayas, Ph.D., University of Metropolitana, San Juan, PR. Abstract # 2279. Mitochondrial membrane permeability and caspases activation of benzazolo[3,2-a]quinolinium chlorides (BQs) on treated A431 tumor cells